Will the Phase 2 trial "Chemoradiotherapy in Elderly Patients With Oesophagus Cancer" reach primary completion on or before Nov 16, 2028?

Resolves Yes if ClinicalTrials.gov record NCT02735057 (Centre Hospitalier Universitaire de Besancon) shows an actual primary completion date on or before Nov 16, 2028. Registered date at generation: Nov 16, 2028.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Nov 16, 2028, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.